Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable disease ...

Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 monthsBiomarker analysis confirms immune activatio ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

However, research has demonstrated that senescent cells can also contribute to cancer development and progression. The tumor-suppressing and tumor-promoting activities are primarily attributable to ...

The evolution of pancreatic cancer screening technologies is pivotal for early detection, addressing key challenges to ...

That's where doctors removed a cystic tumor from her brain. “It was pretty shocking,” Modrall said. She said she started ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Through partnership with Legion Healthcare Partners, proton therapy system will target tumors without "exit radiation" ...